Fenbendazole has gained considerable attention for its potential in cancer treatment, but its effectiveness largely depends on how well it
In recent years, the scientific community has witnessed growing interest in repurposing existing medications to treat cancer. One of the
Thyroid cancer is the most prevalent endocrine malignancy, with papillary thyroid cancer (PTC) accounting for approximately 80% of all thyroid
Fenben Lab, a well-established name in the Fenbendazole market, claims high product quality. However, our investigation reveals concerning practices, including